NEW YORK, May 14 – Gemini Genomics, a clinical genomics company based in Cambridge, UK, posted Monday fourth-quarter revenues of $1.5 million, compared with no revenues in the year ago quarter.

For the company’s 2000 fiscal year, which ended March 31, Gemini recorded revenue of $1.6 million, compared with $200,000 in the year ago period.

The company attributed the increase in revenue to two non-exclusive agreements it signed during the year with CuraGen.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.